JP2014519911A5 - - Google Patents

Download PDF

Info

Publication number
JP2014519911A5
JP2014519911A5 JP2014513592A JP2014513592A JP2014519911A5 JP 2014519911 A5 JP2014519911 A5 JP 2014519911A5 JP 2014513592 A JP2014513592 A JP 2014513592A JP 2014513592 A JP2014513592 A JP 2014513592A JP 2014519911 A5 JP2014519911 A5 JP 2014519911A5
Authority
JP
Japan
Prior art keywords
ecm
composition
thrombospondin
interleukin
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014513592A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014519911A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/039416 external-priority patent/WO2012166539A1/en
Publication of JP2014519911A publication Critical patent/JP2014519911A/ja
Publication of JP2014519911A5 publication Critical patent/JP2014519911A5/ja
Pending legal-status Critical Current

Links

JP2014513592A 2011-05-31 2012-05-24 心不整脈を予防するための組成物 Pending JP2014519911A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161491723P 2011-05-31 2011-05-31
US61/491,723 2011-05-31
US201261650911P 2012-05-23 2012-05-23
US61/650,911 2012-05-23
PCT/US2012/039416 WO2012166539A1 (en) 2011-05-31 2012-05-24 Compositions for preventing cardiac arrhythmia

Publications (2)

Publication Number Publication Date
JP2014519911A JP2014519911A (ja) 2014-08-21
JP2014519911A5 true JP2014519911A5 (https=) 2015-06-18

Family

ID=47259771

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014513592A Pending JP2014519911A (ja) 2011-05-31 2012-05-24 心不整脈を予防するための組成物

Country Status (10)

Country Link
US (2) US8877224B2 (https=)
EP (1) EP2713943A4 (https=)
JP (1) JP2014519911A (https=)
KR (1) KR20140029471A (https=)
AU (1) AU2012262539B2 (https=)
BR (1) BR112013030983A2 (https=)
CA (1) CA2835858A1 (https=)
IL (1) IL229285B (https=)
SG (1) SG194881A1 (https=)
WO (1) WO2012166539A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8962324B2 (en) * 2006-01-18 2015-02-24 Cormatrix Cardiovascular, Inc Method and system for treatment of biological tissue
US8679176B2 (en) 2007-12-18 2014-03-25 Cormatrix Cardiovascular, Inc Prosthetic tissue valve
US8257434B2 (en) 2007-12-18 2012-09-04 Cormatrix Cardiovascular, Inc. Prosthetic tissue valve
BRPI1008628A2 (pt) * 2009-02-18 2016-03-01 Cormatrix Cardiovascular Inc método de tratamento ou prevenção de arritmia cardíaca em um indivíduo
US8696744B2 (en) 2011-05-27 2014-04-15 Cormatrix Cardiovascular, Inc. Extracellular matrix material valve conduit and methods of making thereof
EP2788038A1 (en) * 2011-12-09 2014-10-15 Acell, Inc. Hemostatic device
BR112015014386A2 (pt) * 2012-12-17 2017-09-26 Cormatrix Cardiovascular Inc dispositivo de distribuição de agente intramiocárdico e métodos relacionados
US9801910B2 (en) * 2014-03-17 2017-10-31 Ethicon, Inc. Decellularized pleural matrix
EP3698815B1 (en) 2014-03-21 2024-02-21 University of Pittsburgh- Of the Commonwealth System of Higher Education Terminally sterilized hydrogel derived from extracellular matrix
US11406736B2 (en) 2016-01-13 2022-08-09 University of Pittsburgh—Of the Commonwealth Systems of Higher Education Vascular extracellular matrix hydrogel
CN106726009A (zh) * 2017-03-06 2017-05-31 董念国 主动脉介入瓣制造方法
US10799138B2 (en) 2018-04-05 2020-10-13 University Of Maryland, Baltimore Method of administering sotalol IV/switch
US10512620B1 (en) 2018-08-14 2019-12-24 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US12396970B2 (en) 2021-08-20 2025-08-26 AltaThera Pharmaceuticals LLC Anti-arrhythmic compositions and methods
US11344518B2 (en) 2018-08-14 2022-05-31 AltaThera Pharmaceuticals LLC Method of converting atrial fibrillation to normal sinus rhythm and loading oral sotalol in a shortened time frame
US11610660B1 (en) 2021-08-20 2023-03-21 AltaThera Pharmaceuticals LLC Antiarrhythmic drug dosing methods, medical devices, and systems
US11696902B2 (en) 2018-08-14 2023-07-11 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
WO2020219827A1 (en) * 2019-04-24 2020-10-29 Viadigm, Llc Methods of tissue processing
CN113924360A (zh) * 2019-06-06 2022-01-11 诺和诺德股份有限公司 抗心律失常药向干细胞衍生的心肌细胞的应用及其用途
CA3171384A1 (en) * 2020-02-28 2021-09-02 Texas Medical Center Sprayable stimuli-responsive micro-hydrogels for adhesion prevention and enhanced tissue healing
EP4294328A4 (en) 2021-02-22 2024-11-20 Cormatrix Cardiovascular, Inc. ADAPTABLE FABRIC PROSTHETIC VALVES
CN114569791B (zh) * 2022-01-27 2022-08-30 浙江大学杭州国际科创中心 一种鱼鳔基心肌贴片的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387419A (en) * 1988-03-31 1995-02-07 The University Of Michigan System for controlled release of antiarrhythmic agents
US5900433A (en) * 1995-06-23 1999-05-04 Cormedics Corp. Vascular treatment method and apparatus
EP1572259A2 (en) * 2002-12-05 2005-09-14 Cardio Incorporated Layered bioresorbable implant
AU2003902037A0 (en) * 2003-04-24 2003-05-15 Mclachlan, Craig Method for tissue growth
US7186214B2 (en) * 2004-02-12 2007-03-06 Medtronic, Inc. Instruments and methods for accessing an anatomic space
US8568761B2 (en) * 2005-07-15 2013-10-29 Cormatrix Cardiovascular, Inc. Compositions for regenerating defective or absent myocardium
WO2007035843A2 (en) * 2005-09-21 2007-03-29 Dask Technologies, Llc Methods and compositions for organ and tissue functionality
US8303648B2 (en) * 2006-04-25 2012-11-06 Cook Medical Technologies Llc Artificial venous valve containing therapeutic agent
WO2010042856A2 (en) * 2008-10-09 2010-04-15 The General Hospital Corporation Tissue engineered myocardium and methods of production and uses thereof
US20100310629A1 (en) * 2008-12-23 2010-12-09 Gray Richard J Intrapericardial antiarrhythmic delivery
BRPI1008628A2 (pt) * 2009-02-18 2016-03-01 Cormatrix Cardiovascular Inc método de tratamento ou prevenção de arritmia cardíaca em um indivíduo
US20100239632A1 (en) * 2009-03-23 2010-09-23 Warsaw Orthopedic, Inc. Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
WO2011031299A1 (en) * 2009-08-28 2011-03-17 Mount Sinai School Of Medicine Of New York University Intrapericardial injections

Similar Documents

Publication Publication Date Title
JP2014519911A5 (https=)
Létourneau et al. IL-2–and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets
Jiang et al. Osteoimmunology in orthodontic tooth movement
GB2470689A (en) Differentiation of primate pluripotent stem cells to hematopoietic lineage cells
JP2017525364A5 (https=)
EP2511300A3 (en) High affinity human antibodies to human IL-4 receptor
GB2433943A (en) Cultivation of primate embryonic stem cells
JP2007296371A5 (https=)
WO2010088456A3 (en) Swellable (meth)acrylate surfaces for culturing cells in chemically defined media
JP2012510521A5 (https=)
EP4249586A3 (en) Augmentation of fibroblast regenerative activity
EA201390981A1 (ru) Разрушающаяся во рту таблетка
JP2013543760A5 (https=)
US20150100115A1 (en) Extracellular Matrix Prostheses for Treating Damaged Biological Tissue
Vallés et al. Modulation of the cross-talk between macrophages and osteoblasts by titanium-based particles
ATE374628T1 (de) Milchproteinbiofilm und verwendungen davon
JP2014513126A5 (https=)
JP2005204539A5 (https=)
RU2458985C1 (ru) Способ генерации антиген-специфических цитотоксических клеток с противоопухолевой активностью
MX2023006383A (es) Composicion farmaceutica que contiene anticuerpo anti-factor de crecimiento de tejido conjuntivo.
Maia et al. In vitro evaluation of acellular dermal matrix as a three‐dimensional scaffold for gingival fibroblasts seeding
Tilg et al. Suppression of interleukin-17 by type I interferons: a contributing factor in virus-induced immunosuppression?
EP3916082A4 (en) CULTURE MEDIUM FOR THE PRODUCTION AND CULTURE OF HUMAN HEPATIC PROGENITOR CELLS AND THEIR APPLICATION
EP2001993A4 (en) INCREASING CELL CULTURE DOUBLES FOR LONG-TERM GROWTH OF CELLULAR CULTURES WITH A DETERMINED LIFETIME
Bethel et al. Hematopoietic cell regulation of osteoblast proliferation and differentiation